Anatibant - CISMeF

Preferred Label : Anatibant;

NCIt synonyms : (2S)-N-(3-(4-Carbamimidoylbenzamido)propyl)-1-{2,4-dichloro-3-((2,4-dimethyl-8-quinolyloxy)methyl)phenylsulfonyl}pyrrolidine-2-carboxamide; 1-([2, 4-dichloro-3-{([2,4-dimethylquinolin-8-yl]oxy)methyl}phenyl]sulfonyl)-N-(3-[{4-(aminoimethyl)phenyl}carbonylamino]propyl)-2(S)-pyrrolidinecarboxamide;

UNII : CLO4JRD21F;

InChIKey : XUHBBTKJWIBQMY-MHZLTWQESA-N;

CAS number : 209733-45-9;

Molecule name : LF160687; XY-2405;

Chemical formula : C34H36Cl2N6O5S;

Details

Origin ID

C79554;

UMLS CUI

C2718119;

Automatic exact mappings (from CISMeF team)
- LF 16-0687 [MeSH Supplementary Concept]
Currated CISMeF NLP mapping
- anatibant [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- anatibant [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients